Stanislav Glezer is EVP, R&D & Chief Med. Officer of Inogen Inc. Currently has a direct ownership of 32,049 shares of INGN, which is worth approximately $313,439. The most recent transaction as insider was on May 01, 2024, when has been sold 16,695 shares (Common Stock) at a price of $7.05 per share, resulting in proceeds of $117,699. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32K
0% 3M change
322.2% 12M change
Total Value Held $313,439

Stanislav Glezer Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
SELL
Payment of exercise price or tax liability
$117,699 $7.05 p/Share
16,695 Reduced 34.25%
32,049 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
32,638 Added 40.1%
48,744 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$53,589 $7.03 p/Share
7,623 Reduced 32.13%
16,106 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
-
13,914 Added 36.96%
23,729 Common Stock
Dec 01 2023
SELL
Payment of exercise price or tax liability
$13,333 $5.72 p/Share
2,331 Reduced 19.19%
9,815 Common Stock
Dec 01 2023
BUY
Exercise of conversion of derivative security
-
4,555 Added 27.27%
12,146 Common Stock
Sep 01 2023
SELL
Payment of exercise price or tax liability
$2,434 $6.18 p/Share
394 Reduced 4.93%
7,591 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
-
769 Added 8.78%
7,985 Common Stock
Jun 01 2023
SELL
Payment of exercise price or tax liability
$4,075 $10.37 p/Share
393 Reduced 5.16%
7,216 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
768 Added 9.17%
7,609 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$57,727 $15.56 p/Share
3,710 Reduced 35.16%
6,841 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
2,272 Added 27.48%
5,995 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
-
4,556 Added 32.62%
9,409 Common Stock
Dec 01 2022
SELL
Payment of exercise price or tax liability
$53,356 $22.89 p/Share
2,331 Reduced 38.5%
3,723 Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
-
4,555 Added 42.94%
6,054 Common Stock
Sep 01 2022
SELL
Open market or private sale
$44,380 $28.16 p/Share
1,576 Reduced 51.25%
1,499 Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
-
3,075 Added 50.0%
3,075 Common Stock
SG

Stanislav Glezer

EVP, R&D & Chief Med. Officer
Goleta, CA

Track Institutional and Insider Activities on INGN

Follow Inogen Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INGN shares.

Notify only if

Insider Trading

Get notified when an Inogen Inc insider buys or sells INGN shares.

Notify only if

News

Receive news related to Inogen Inc

Track Activities on INGN